Shareholder alert: ademi llp investigates whether adamas pharmaceuticals, inc. has obtained a fair price in its transaction with supernus

Milwaukee, oct. 11, 2021 /prnewswire/ -- ademi llp is investigating adamas (nasdaq: adms), for possible breaches of fiduciary duty and other violations of law in its transaction with supernus. click here to learn how to join the action: https://www.ademilaw.com/case/adamas-pharmaceuticals-inc or call guri ademi toll-free at 866-264-3995.
ADMS Ratings Summary
ADMS Quant Ranking